News
QDEL
17.32
+7.71%
1.24
Weekly Report: what happened at QDEL last week (0406-0410)?
Weekly Report · 1d ago
QuidelOrtho Price Target Cut to $17.00/Share From $30.00 by UBS
Dow Jones · 4d ago
QuidelOrtho Is Maintained at Neutral by UBS
Dow Jones · 4d ago
UBS Maintains Neutral on QuidelOrtho, Lowers Price Target to $17
Benzinga · 4d ago
QUIDELORTHO CORP <QDEL.O>: UBS CUTS TARGET PRICE TO $17 FROM $30
Reuters · 4d ago
QuidelOrtho price target lowered to $17 from $30 at UBS
TipRanks · 4d ago
U.S. RESEARCH ROUNDUP-Chevron, Littelfuse, Parker-Hannifin
Reuters · 4d ago
QuidelOrtho (QDEL) Is Down 18.0% After Proposed NIH Funding Cuts Raised Diagnostics Demand Questions
Simply Wall St · 4d ago
Is It Time To Reassess QuidelOrtho (QDEL) After The Recent Share Price Slump?
Simply Wall St · 04/07 18:15
Guardant Health, Organon, Fortrea, QuidelOrtho, and Charles River Laboratories Stocks Trade Down, What You Need To Know
Barchart · 04/06 14:54
Weekly Report: what happened at QDEL last week (0330-0403)?
Weekly Report · 04/06 10:06
QuidelOrtho (QDEL) Valuation Check After Prolonged Share Price Weakness
Simply Wall St · 04/05 23:14
QuidelOrtho CLO Nathaniel Sisitsky files initial beneficial ownership statement
Reuters · 03/31 20:21
Weekly Report: what happened at QDEL last week (0323-0327)?
Weekly Report · 03/30 10:06
Align Technology, QuidelOrtho, DexCom, Insulet, and Omnicell Shares Are Falling, What You Need To Know
Barchart · 03/27 13:16
QuidelOrtho EVP Global Portfolio Management and Marketing Bryan Michael Hanson files initial beneficial ownership statement
Reuters · 03/24 20:41
QuidelOrtho Announces Chief Legal Officer Leadership Transition
TipRanks · 03/24 11:32
QuidelOrtho names Nathaniel Sisitsky chief legal officer
Reuters · 03/24 11:01
Press Release: Nathaniel Sisitsky Joins QuidelOrtho as Chief Legal Officer
Dow Jones · 03/24 11:00
*Nathaniel Sisitsky Joins QuidelOrtho as Chief Legal Officer
Dow Jones · 03/24 11:00
More
Webull provides a variety of real-time QDEL stock news. You can receive the latest news about Quidel through multiple platforms. This information may help you make smarter investment decisions.
About QDEL
QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics and Ortho Optix.